4
|
Nijjer SS, Petraco R, van de Hoef TP, Sen S, van Lavieren MA, Foale RA, Meuwissen M, Broyd C, Echavarria-Pinto M, Al-Lamee R, Foin N, Sethi A, Malik IS, Mikhail GW, Hughes AD, Mayet J, Francis DP, Di Mario C, Escaned J, Piek JJ, Davies JE. Change in coronary blood flow after percutaneous coronary intervention in relation to baseline lesion physiology: results of the JUSTIFY-PCI study. Circ Cardiovasc Interv 2016; 8:e001715. [PMID: 26025217 DOI: 10.1161/circinterventions.114.001715] [Citation(s) in RCA: 36] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
BACKGROUND Percutaneous coronary intervention (PCI) aims to increase coronary blood flow by relieving epicardial obstruction. However, no study has objectively confirmed this and assessed changes in flow over different phases of the cardiac cycle. We quantified the change in resting and hyperemic flow velocity after PCI in stenoses defined physiologically by fractional flow reserve and other parameters. METHODS AND RESULTS Seventy-five stenoses (67 patients) underwent paired flow velocity assessment before and after PCI. Flow velocity was measured over the whole cardiac cycle and the wave-free period. Mean fractional flow reserve was 0.68±0.02. Pre-PCI, hyperemic flow velocity is diminished in stenoses classed as physiologically significant compared with those classed nonsignificant (P<0.001). In significant stenoses, flow velocity over the resting wave-free period and hyperemic flow velocity did not differ statistically. After PCI, resting flow velocity over the wave-free period increased little (5.6±1.6 cm/s) and significantly less than hyperemic flow velocity (21.2±3 cm/s; P<0.01). The greatest increase in hyperemic flow velocity was observed when treating stenoses below physiological cut points; treating stenoses with fractional flow reserve ≤0.80 gained Δ28.5±3.8 cm/s, whereas those fractional flow reserve >0.80 had a significantly smaller gain (Δ4.6±2.3 cm/s; P<0.001). The change in pressure-only physiological indices demonstrated a curvilinear relationship to the change in hyperemic flow velocity but was flat for resting flow velocity. CONCLUSIONS Pre-PCI physiology is strongly associated with post-PCI increase in hyperemic coronary flow velocity. Hyperemic flow velocity increases 6-fold more when stenoses classed as physiologically significant undergo PCI than when nonsignificant stenoses are treated. Resting flow velocity measured over the wave-free period changes at least 4-fold less than hyperemic flow velocity after PCI.
Collapse
Affiliation(s)
- Sukhjinder S Nijjer
- From the National Heart and Lung Institute, Imperial College London, London, United Kingdom (S.S.N., R.P., S.S., R.A.F., C.B., R.A.-L., N.F., A.S., I.S.M., G.W.M., A.D.H., J.M., D.P.F., C.D.M., J.E.D.); AMC Heart Centre, Amsterdam Medical Centre, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Department of Cardiology, Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular National Institute of Health Research Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Ricardo Petraco
- From the National Heart and Lung Institute, Imperial College London, London, United Kingdom (S.S.N., R.P., S.S., R.A.F., C.B., R.A.-L., N.F., A.S., I.S.M., G.W.M., A.D.H., J.M., D.P.F., C.D.M., J.E.D.); AMC Heart Centre, Amsterdam Medical Centre, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Department of Cardiology, Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular National Institute of Health Research Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Tim P van de Hoef
- From the National Heart and Lung Institute, Imperial College London, London, United Kingdom (S.S.N., R.P., S.S., R.A.F., C.B., R.A.-L., N.F., A.S., I.S.M., G.W.M., A.D.H., J.M., D.P.F., C.D.M., J.E.D.); AMC Heart Centre, Amsterdam Medical Centre, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Department of Cardiology, Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular National Institute of Health Research Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Sayan Sen
- From the National Heart and Lung Institute, Imperial College London, London, United Kingdom (S.S.N., R.P., S.S., R.A.F., C.B., R.A.-L., N.F., A.S., I.S.M., G.W.M., A.D.H., J.M., D.P.F., C.D.M., J.E.D.); AMC Heart Centre, Amsterdam Medical Centre, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Department of Cardiology, Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular National Institute of Health Research Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Martijn A van Lavieren
- From the National Heart and Lung Institute, Imperial College London, London, United Kingdom (S.S.N., R.P., S.S., R.A.F., C.B., R.A.-L., N.F., A.S., I.S.M., G.W.M., A.D.H., J.M., D.P.F., C.D.M., J.E.D.); AMC Heart Centre, Amsterdam Medical Centre, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Department of Cardiology, Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular National Institute of Health Research Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Rodney A Foale
- From the National Heart and Lung Institute, Imperial College London, London, United Kingdom (S.S.N., R.P., S.S., R.A.F., C.B., R.A.-L., N.F., A.S., I.S.M., G.W.M., A.D.H., J.M., D.P.F., C.D.M., J.E.D.); AMC Heart Centre, Amsterdam Medical Centre, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Department of Cardiology, Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular National Institute of Health Research Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Martijn Meuwissen
- From the National Heart and Lung Institute, Imperial College London, London, United Kingdom (S.S.N., R.P., S.S., R.A.F., C.B., R.A.-L., N.F., A.S., I.S.M., G.W.M., A.D.H., J.M., D.P.F., C.D.M., J.E.D.); AMC Heart Centre, Amsterdam Medical Centre, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Department of Cardiology, Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular National Institute of Health Research Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Christopher Broyd
- From the National Heart and Lung Institute, Imperial College London, London, United Kingdom (S.S.N., R.P., S.S., R.A.F., C.B., R.A.-L., N.F., A.S., I.S.M., G.W.M., A.D.H., J.M., D.P.F., C.D.M., J.E.D.); AMC Heart Centre, Amsterdam Medical Centre, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Department of Cardiology, Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular National Institute of Health Research Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Mauro Echavarria-Pinto
- From the National Heart and Lung Institute, Imperial College London, London, United Kingdom (S.S.N., R.P., S.S., R.A.F., C.B., R.A.-L., N.F., A.S., I.S.M., G.W.M., A.D.H., J.M., D.P.F., C.D.M., J.E.D.); AMC Heart Centre, Amsterdam Medical Centre, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Department of Cardiology, Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular National Institute of Health Research Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Rasha Al-Lamee
- From the National Heart and Lung Institute, Imperial College London, London, United Kingdom (S.S.N., R.P., S.S., R.A.F., C.B., R.A.-L., N.F., A.S., I.S.M., G.W.M., A.D.H., J.M., D.P.F., C.D.M., J.E.D.); AMC Heart Centre, Amsterdam Medical Centre, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Department of Cardiology, Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular National Institute of Health Research Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Nicolas Foin
- From the National Heart and Lung Institute, Imperial College London, London, United Kingdom (S.S.N., R.P., S.S., R.A.F., C.B., R.A.-L., N.F., A.S., I.S.M., G.W.M., A.D.H., J.M., D.P.F., C.D.M., J.E.D.); AMC Heart Centre, Amsterdam Medical Centre, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Department of Cardiology, Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular National Institute of Health Research Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Amarjit Sethi
- From the National Heart and Lung Institute, Imperial College London, London, United Kingdom (S.S.N., R.P., S.S., R.A.F., C.B., R.A.-L., N.F., A.S., I.S.M., G.W.M., A.D.H., J.M., D.P.F., C.D.M., J.E.D.); AMC Heart Centre, Amsterdam Medical Centre, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Department of Cardiology, Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular National Institute of Health Research Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Iqbal S Malik
- From the National Heart and Lung Institute, Imperial College London, London, United Kingdom (S.S.N., R.P., S.S., R.A.F., C.B., R.A.-L., N.F., A.S., I.S.M., G.W.M., A.D.H., J.M., D.P.F., C.D.M., J.E.D.); AMC Heart Centre, Amsterdam Medical Centre, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Department of Cardiology, Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular National Institute of Health Research Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Ghada W Mikhail
- From the National Heart and Lung Institute, Imperial College London, London, United Kingdom (S.S.N., R.P., S.S., R.A.F., C.B., R.A.-L., N.F., A.S., I.S.M., G.W.M., A.D.H., J.M., D.P.F., C.D.M., J.E.D.); AMC Heart Centre, Amsterdam Medical Centre, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Department of Cardiology, Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular National Institute of Health Research Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Alun D Hughes
- From the National Heart and Lung Institute, Imperial College London, London, United Kingdom (S.S.N., R.P., S.S., R.A.F., C.B., R.A.-L., N.F., A.S., I.S.M., G.W.M., A.D.H., J.M., D.P.F., C.D.M., J.E.D.); AMC Heart Centre, Amsterdam Medical Centre, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Department of Cardiology, Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular National Institute of Health Research Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Jamil Mayet
- From the National Heart and Lung Institute, Imperial College London, London, United Kingdom (S.S.N., R.P., S.S., R.A.F., C.B., R.A.-L., N.F., A.S., I.S.M., G.W.M., A.D.H., J.M., D.P.F., C.D.M., J.E.D.); AMC Heart Centre, Amsterdam Medical Centre, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Department of Cardiology, Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular National Institute of Health Research Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Darrel P Francis
- From the National Heart and Lung Institute, Imperial College London, London, United Kingdom (S.S.N., R.P., S.S., R.A.F., C.B., R.A.-L., N.F., A.S., I.S.M., G.W.M., A.D.H., J.M., D.P.F., C.D.M., J.E.D.); AMC Heart Centre, Amsterdam Medical Centre, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Department of Cardiology, Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular National Institute of Health Research Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Carlo Di Mario
- From the National Heart and Lung Institute, Imperial College London, London, United Kingdom (S.S.N., R.P., S.S., R.A.F., C.B., R.A.-L., N.F., A.S., I.S.M., G.W.M., A.D.H., J.M., D.P.F., C.D.M., J.E.D.); AMC Heart Centre, Amsterdam Medical Centre, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Department of Cardiology, Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular National Institute of Health Research Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Javier Escaned
- From the National Heart and Lung Institute, Imperial College London, London, United Kingdom (S.S.N., R.P., S.S., R.A.F., C.B., R.A.-L., N.F., A.S., I.S.M., G.W.M., A.D.H., J.M., D.P.F., C.D.M., J.E.D.); AMC Heart Centre, Amsterdam Medical Centre, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Department of Cardiology, Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular National Institute of Health Research Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Jan J Piek
- From the National Heart and Lung Institute, Imperial College London, London, United Kingdom (S.S.N., R.P., S.S., R.A.F., C.B., R.A.-L., N.F., A.S., I.S.M., G.W.M., A.D.H., J.M., D.P.F., C.D.M., J.E.D.); AMC Heart Centre, Amsterdam Medical Centre, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Department of Cardiology, Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular National Institute of Health Research Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Justin E Davies
- From the National Heart and Lung Institute, Imperial College London, London, United Kingdom (S.S.N., R.P., S.S., R.A.F., C.B., R.A.-L., N.F., A.S., I.S.M., G.W.M., A.D.H., J.M., D.P.F., C.D.M., J.E.D.); AMC Heart Centre, Amsterdam Medical Centre, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Department of Cardiology, Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular National Institute of Health Research Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.).
| |
Collapse
|